- Abbott stock slips on guidance cut, ranks 10th in healthcare equipment Quant ratings Seeking Alpha —
- Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt Sales Wall Street Journal —
- Abbott forecasts 6.5%-7.5% 2026 comparable sales growth while integrating Exact Sciences with $0.20 EPS dilution Seeking Alpha —
- Abbott trims 2026 profit forecast on Exact deal hit, shares fall - Reuters Reuters —
- Abbott trims 2026 profit forecast on Exact deal hit, shares fall The Globe and Mail —
- Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Biting. Barrons —
Exact Sciences
American company in Madison, United States
Exact Sciences Corporation is an American molecular diagnostics company based in Madison, Wisconsin, specializing in the detection of early-stage cancers. The company provides products for the detection and prevention of colorectal cancer, including Cologuard, the first stool DNA test for colorectal cancer, along with additional screening and precision oncological tests for other types of cancer.
Also known as...
Exact Sciences (United States)
Abbott trims profit forecast